We’re progressing
#CancerCare
through innovative immunotherapies, leading with BsAbs. Read the full science story in
@OncLive
to learn how our team is pushing the boundaries of clinical research to treat currently incurable cancers like
#MultipleMyeloma
.
Through Accord for a Healthier World, Pfizer is working to address unmet healthcare needs in lower income countries. Learn more about the Accord:
#HealthEquity
We’re sharing new overall survival data at
#EHA24
from a Phase 2 study in patients with heavily pretreated relapsed or refractory
#MultipleMyeloma
(RRMM). Learn more about our latest advancements in MM treatment.
With 115 million adults impacted by fatty liver disease around the world, Global Fatty Liver Day is a crucial moment to amplify awareness, drive prevention efforts, support patients and prioritize early detection.
#FattyLiverDay
As we approach
#EHA24
, we’re excited to be sharing data across our
#BloodCancer
portfolio as we contribute to the latest scientific discussions in innovative medicine, including advancements in
#MultipleMyeloma
treatment.
For nearly two centuries, Pfizer has been a trusted partner in healthcare all over the globe. As we celebrate our 175th anniversary, learn how we got started—and how we plan to outdo yesterday with more breakthroughs that change patients' lives:
So much has changed since we were founded in 1849. But not our commitment to finding innovations that help people. We’re continuing to expand the limits of science, harnessing unprecedented technologies and ground-breaking therapies. Happy 175 yrs Pfizer!
Today at
#ASCO24
, we presented new Phase 1 data for our potential first-in-class investigational treatment for people with ER+/HER2- metastatic
#BreastCancer
.
Our vision is a world where people with cancer live longer and better lives. We’re looking forward to
#ASCO24
to showcase the latest data spanning our portfolio and innovative pipeline.
Learn more:
We honor the
#TrailblazersAmongUs
who work with us to advance science and medicine. They are the heroes behind every breakthrough. Thank you for helping to make the impossible possible on
#ClinicalTrialsDay
and every day.
With
@ArvinasInc
we announced updated Phase 1b data at
#ESMOBreast24
for our investigational treatment combination in patients with locally advanced or metastatic estrogen receptor positive/human epidermal growth factor 2 negative breast cancer. Learn more
Congratulations to Dr.
@tompowles1
, who was newly recognized as one of
@TIME
’s most influential people in health. It is truly an honor to work with you in support of our efforts to advance
#breakthroughs
to change
#BladderCancer
care.
For 175 yrs, we have been discovering, developing, and delivering breakthroughs that change patients’ lives.Our first breakthrough in 1849 was a groundbreaking way to treat parasites.We continued on to become the world’s largest producer of the “miracle drug” during World War II.
Metastatic melanoma is the most aggressive form of skin cancer, but that hasn't stopped Bruce, and his wife Chris, from enjoying full lives. Read about Bruce and Chris's story:
#BladderCancer
is the 9th most diagnosed cancer globally. This
#BladderCancerAwarenessMonth
and every month, we’re standing alongside this community to raise awareness and provide steadfast support. Learn more about our efforts in tackling cancer:
For over 70 years, we've strived to achieve progress and breakthroughs in inflammation, including for the millions of people living with arthritis. This
#ArthritisAwarenessMonth
, we’re continuing to support this community.
The FDA grants full approval of our therapy for the treatment of recurrent or metastatic
#CervicalCancer
, developed with our partner
@Genmab
Read More About Today’s Announcement: